Results 91 to 100 of about 46,290 (201)
The effect of time on associations between historical redlining and breast cancer survival
Cancer, Volume 132, Issue 4, 15 February 2026.Abstract Background Historical redlining, a 1930s residential segregation policy, has been associated with shorter breast cancer survival. It is unknown whether this disparity has changed over time, given the time since redlining increases and subsequent breast cancer advances have occurred.
Sarah M. Lima +8 more
wiley +1 more source
Machine learning methods for predicting adverse drug events: A systematic review
British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 422-444, February 2026.Abstract Predicting adverse drug events (ADEs) in outpatient settings is crucial for improving medication safety, identifying high‐risk patients and reducing health‐care costs. While traditional methods struggle with the complexity of health‐care data, machine learning (ML) models offer improved prediction capabilities; however, their effectiveness in ...
Niaz Chalabianloo +8 more
wiley +1 more source
Cardiac digital twins: Modelling the arrhythmic substrate of chemotherapy
The Journal of Physiology, EarlyView.
Radomir Chabiniok, Vlad G. Zaha
wiley +1 more source
Prognosis of Metaplastic Breast Cancer: A Population‐Based Matched Cohort Study
Cancer Medicine, Volume 15, Issue 2, February 2026.ABSTRACT Purpose Metaplastic breast cancer (metBC) is a rare subtype of breast cancer known for its challenging management. The impact of this histological subtype on prognosis remains unclear. Methods Data were collected from the Swedish Cancer Registry between 2008 and 2018.
Marie Bergman +6 more
wiley +1 more source
Nipple‐Originating Solid Papillary Carcinoma In Situ: A Case Report and Literature Review
Clinical Case Reports, Volume 14, Issue 2, February 2026.ABSTRACT Solid papillary carcinoma of the breast is a rare histopathological subtype of papillary neoplasms, and its in situ variant localized to the nipple is particularly uncommon. Current oncology literature provides limited evidence on standardized diagnostic criteria, biological behavior, and optimal treatment strategies for this entity.
Yuying Yang +4 more
wiley +1 more source
Cancer Reports, Volume 9, Issue 2, February 2026.ABSTRACT Background Orbital metastases are rare in patients with breast cancer. However, medical management of orbital metastases is limited by the inability of treatment options to penetrate the blood‐brain barrier. In patients with triple negative breast cancer (TNBC), these treatment options are further limited.
Nellie Nafissi +4 more
wiley +1 more source
Clinical and Translational Medicine, Volume 16, Issue 2, February 2026.This review systematically deconstructs the pathological efferocytic—metabolic axis in tumours, framing it as a three‐stage, self‐reinforcing cycle: from metabolite‐driven macrophage recruitment, through hijacked surface recognition, to post‐phagocytic metabolic reprogramming that locks in immunosuppression.
Qianlu Yang, Jie Yan, Qianxi Yang
wiley +1 more source
Comparing efficacy of neoadjuvant therapy of triple-negative breast cancer: A Bayesian network meta-regression analysis. [PDF]
Medicine (Baltimore)Jiang Y +8 more
europepmc +1 more source
Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.ABSTRACT Background Patients with haematological cancer often exhibit reduced cardiorespiratory fitness and an elevated risk of cardiovascular disease. The mechanisms underlying this impairment are multifactorial, but the contribution of skeletal muscle fat infiltration has not been evaluated.
Nicholas J. Saner +7 more
wiley +1 more source
Clinical experience with lapatinib in patients with ErbB2-overexpressing metastatic breast cancer [PDF]
, 2008 Blackwell KL +13 more
core +3 more sources